The fund will be managed by Aditya Khemani and will be benchmarked against the BSE Healthcare TRI
Invesco Mutual Fund has launched India Pharma and Healthcare Fund which will invest across pharmaceutical companies, hospitals, diagnostics, contract development and manufacturing organisations, contract research organisations, medical devices, healthcare services, insurance and other allied healthcare segments.
The fund seeks to capitalise on India’s evolving healthcare ecosystem, which is being shaped by favourable demographics, expanding healthcare access and rising insurance penetration.
India today occupies a unique position in the global healthcare ecosystem, supported by its scale, talent pool, manufacturing capabilities and growing innovation footprint.
The fund will be managed by Aditya Khemani and will be benchmarked against the BSE Healthcare TRI.
Aditya Khemani, Head of Equity and Fund Manager, Invesco MF, said the country is not only witnessing rising healthcare consumption driven by favourable demographics and increasing affordability but also strengthening its position as a global pharmaceutical and healthcare innovation hub.
The investment approach will focus on identifying quality businesses with sustainable competitive advantages and strong growth visibility across the healthcare ecosystem, he said.
The New Fund Offer closes for subscription on September 1.
Published on August 18, 2026